MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells

Stem Cells

Volumn 29, Issue 11, 2011, Pages 1661-1671

  Bitarte, Nerea ^a   Bandres, Eva ^a   Boni, Valentina ^a,b   Zarate, Ruth ^a   Rodriguez, Javier ^b   Gonzalez Huarriz, Marisol ^a   Lopez, Ines ^a   Sola, Jesus Javier ^c   Alonso, Marta M ^b   Fortes, Puri ^b,c   Garcia Foncillas, Jesus ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

ABCB1; Cancer stem cells; Chemoresistance; Colorectal cancer; Cyclooxygenase 2; Irinotecan; MicroRNA

Indexed keywords

CD133 ANTIGEN; CYCLOOXYGENASE 2; HERMES ANTIGEN; IRINOTECAN; MACROPHAGE MIGRATION INHIBITION FACTOR; MICRORNA; MICRORNA 114; MICRORNA 451; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STEM CELL; CANCER TISSUE; CARCINOGENICITY; CELL PROLIFERATION; CELL RENEWAL; CHEMOSENSITIVITY; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CAMPTOTHECIN; CELL LINE; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80054924979     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.741     Document Type: Article

References (39)

1. Cammareri P, Lombardo Y, Francipane MG et al. Isolation and culture of colon cancer stem cells. Methods Cell Biol 2008;86:311-324.
2. Boman BM, Huang E. Human colon cancer stem cells: A new paradigm in gastrointestinal oncology. J Clin Oncol 2008;26:2828-2838.
3. Dallas NA, Xia L, Fan F et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009;69:1951-1957.
4. Huang EH, Wicha MS. Colon cancer stem cells: Implications for prevention and therapy. Trends Mol Med 2008;14:503-509.
5. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-355. (Pubitemid 39265675)
6. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006;94:776-780.
7. Calin GA, Liu CG, Sevignani C et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755-11760. (Pubitemid 39095368)
8. Ji Q, Hao X, Zhang M et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 2009;4:e6816.
9. Song B, Wang Y, Xi Y et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009;28:4065-4074.
10. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-115. (Pubitemid 46067311)
11. Fang DD, Kim YJ, Lee CN et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 2010;102:1265-1275.
12. Zarate R, Rodriguez J, Bandres E et al. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): A dose-finding study and pharmacogenomic analysis. Br J Cancer 2010;102:987-994.
13. Kye MJ, Liu T, Levy SF et al. Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. RNA 2007;13:1224-1234. (Pubitemid 47080468)
14. Papapetrou EP, Korkola JE, Sadelain M. A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells 2010;28:287-296.
15. Godlewski J, Nowicki MO, Bronisz A et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 2010;37:620-632.
16. Bandres E, Bitarte N, Arias F et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009;15:2281-2290.
17. Vermeulen L, De Sousa EMF, van der Heijden M et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010;12:468-476.
18. Xin D, Rendon BE, Zhao M et al. The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through beta-catenin-dependent and -independent mechanisms. Mol Cancer Res 2010;8:1601-1609.
19. Carli C, Metz CN, Al-Abed Y et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: Involvement of novel kinase signaling pathways. Endocrinology 2009;150:3128-3137.
20. Mitchell RA, Liao H, Chesney J et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002;99:345-350. (Pubitemid 34060365)
21. Castellone MD, Teramoto H, Williams BO et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005;310:1504-1510. (Pubitemid 41746348)
22. Chu XY, Kato Y, Ueda K et al. Biliary excretion mechanism of CPT-11 and its metabolites in humans: Involvement of primary active transporters. Cancer Res 1998;58:5137-5143. (Pubitemid 28521174)
23. Kovalchuk O, Filkowski J, Meservy J et al. Involvement of micro-RNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008;7:2152-2159.
24. Thenappan A, Li Y, Shetty K et al. New therapeutics targeting colon cancer stem cells. Curr Colorectal Cancer Rep 2009;5:209.
25. Choi D, Lee HW, Hur KY et al. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 2009;15:2258-2264.
26. Zhang H, Li W, Nan F et al. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem Biophys Res Commun 2010;404:273-278.
27. Wang R, Wang ZX, Yang JS et al. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011;30:2644-2658.
28. Nan Y, Han L, Zhang A et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 2010;1359:14-21.
29. Gal H, Pandi G, Kanner AA et al. MIR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem Biophys Res Commun 2008;376:86-90.
30. Hui AB, Lenarduzzi M, Krushel T et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010;16:1129-1139.
31. Zhan M, Miller CP, Papayannopoulou T et al. MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol 2007;35:1015-1025. (Pubitemid 46921304)
32. Masaki S, Ohtsuka R, Abe Y et al. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 2007;364:509-514. (Pubitemid 350026496)
33. Pase L, Layton JE, Kloosterman WP et al. miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood 2009;113:1794-1804.
34. Tsuchiya S, Oku M, Imanaka Y et al. MicroRNA-338-3p and micro-RNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res 2009;37:3821-3827.
35. Singh B, Cook KR, Vincent L et al. Role of COX-2 in tumorospheres derived from a breast cancer cell line. J Surg Res 2011;168:e39-e49.
36. de Sousa EM, Vermeulen L, Richel D et al. Targeting Wnt signaling in colon cancer stem cells. Clin Cancer Res 2010;17:647-653.
37. Zhu H, Wu H, Liu X et al. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008;76:582-588.
38. Minderman H, O'Loughlin KL, Pendyala L et al. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Clin Cancer Res 2004;10:1826-1834. (Pubitemid 38435574)
39. Emmink BL, Van Houdt WJ, Vries RG et al. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology 2011;141:269-278.